International Nonproprietary Name (INN): Ferrous (III) Hydroxide Polymaltose Complex
Clinical-Pharmacological Group: Hematology → Antianemic preparations → Iron preparations → Oral use.
Composition
1 ml syrup contains:
5 ml syrup (1 measuring spoon) contains:
Excipients:
Sucrose, Sorbitol Solution, Methyl Parahydroxybenzoate, Propyl Parahydroxybenzoate, Ethanol 96%, Cream Flavor, Purified Water, Sodium Hydroxide.
Description
Brown transparent solution.
Pharmacological Group
Antianemic preparations, iron preparations, oral ferric iron preparations.
Indications
Contraindications
Dosage and Administration
For oral use.
Take during or immediately after meals.
The syrup may be mixed with fruit or vegetable juice or added to infant formula. Use the measuring spoon provided for accurate dosing.
A slight discoloration does not affect the taste of the food/juice or the effectiveness of the medicine.
The daily dose may be taken once daily or divided into several doses.
The dosage and duration of treatment depend on the severity of iron deficiency.
Manifest Iron Deficiency
Treatment should continue for 3–5 months until hemoglobin levels return to normal.
After normalization, treatment should continue for several additional weeks to replenish iron stores.
Latent Iron Deficiency
Treatment should continue for 1–2 months.
Pregnant Women
Manifest Iron Deficiency:
Latent Iron Deficiency and Prevention of Iron Deficiency:
- 10 mg Iron (III) Hydroxide Polymaltose Complex.
- 50 mg Iron (III) Hydroxide Polymaltose Complex.
- Treatment of latent iron deficiency.
- Treatment of iron deficiency anemia (manifest iron deficiency).
- Prevention of iron deficiency during pregnancy.
- Hypersensitivity to the active substance or any excipient.
- Iron overload (e.g., hemochromatosis, hemosiderosis) and disorders of iron utilization (e.g., sideroachrestic anemia, lead poisoning anemia, thalassemia).
- Anemia not caused by iron deficiency (e.g., hemolytic anemia, megaloblastic anemia due to vitamin B12 deficiency).
- Repeated blood transfusions.
- Parenteral therapy with iron preparations.
- Children under 1 year: Initial dose: 2.5 ml (½ measuring spoon), gradually increased to 5 ml (1 measuring spoon) daily.
- Children 1–12 years: 5–10 ml (1–2 measuring spoons) daily.
- Children over 12 years, adults, and breastfeeding women: 10–30 ml (2–6 measuring spoons) daily.
- Children under 1 year: Not recommended for this indication.
- Children 1–12 years: 2.5–5 ml (½–1 measuring spoon) daily.
- Children over 12 years, adults, and breastfeeding women: 5–10 ml (1–2 measuring spoons) daily.
- 20–30 ml (4–6 measuring spoons) daily until hemoglobin levels normalize.
- Then 10 ml (2 measuring spoons) daily, if necessary until the end of pregnancy, to replenish iron stores.
- 5–10 ml (1–2 measuring spoons) daily.
